Michael Christmass
Dados Biográficos
| ID | 7446997 |
|---|---|
| NOME | Michael Christmass |
| PRENOMES | Michael |
| SOBRENOME | Christmass |
| ASSINATURA | CHRISTMASS M |
| AFILIAÇÕES | Curtin University |
| ORCID | 0000-0001-9782-1849 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 12 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 12 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Cupping a solution
Background Hepatitis C is a life-threatening blood-borne virus linked to intravenous drug use. This study aimed to develop the feasibility and acceptability of a new recruitment strategy incentivizing community program for opioid pharmacotherapy clients to undergo hepatitis C virus (HCV) screening.Methods Non-experimental descriptive research study design. Clients received a monetary incentive for returning a cup provided with their opioid substi…
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Injecting hope
Background This study aimed to assess the feasibility of implementing a community pharmacy–based needle-syringe program (NSP) that provides free needle packs and monetary incentives to recruit people who currently inject drugs for hepatitis C virus (HCV) screening.Method Non-experimental descriptive research study design. Participants were recruited from a community pharmacy NSP in Perth, Western Australia. They received a Fitstick® 5 Plus pack a…
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia
Participant experiences in a pilot study for methamphetamine withdrawal treatment
The experiences of participants in this clinical trial can be distilled into four meta-themes: agency, caring-trust, safety, and communication. Participants spontaneously linked these experiences with a capacity to remain enrolled in the study. By considering the experiences of trial participants in clinical trial design, researchers can improve the experiences of future trial participants and facilitate their choice to remain enrolled in clinica…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Perspectives and sentiments on contingency management from people who use methamphetamine
I just thought that was the best thing for me to do at this point’
Depot buprenorphine remains a promising treatment for OUD and offers potential to improve treatment adherence. Instances of restricted OAT choice and consumer concerns regarding a lack of agency must be addressed in order to enhance therapeutic relationships. Clinicians and other healthcare workers in this field also need greater access to information about depot buprenorphine to better address issues patients face during treatment. More research…
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Sem obras proeminentes nesta página.
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Perspectives and sentiments on contingency management from people who use methamphetamine
I just thought that was the best thing for me to do at this point’
Depot buprenorphine remains a promising treatment for OUD and offers potential to improve treatment adherence. Instances of restricted OAT choice and consumer concerns regarding a lack of agency must be addressed in order to enhance therapeutic relationships. Clinicians and other healthcare workers in this field also need greater access to information about depot buprenorphine to better address issues patients face during treatment. More research…
The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia
Participant experiences in a pilot study for methamphetamine withdrawal treatment
The experiences of participants in this clinical trial can be distilled into four meta-themes: agency, caring-trust, safety, and communication. Participants spontaneously linked these experiences with a capacity to remain enrolled in the study. By considering the experiences of trial participants in clinical trial design, researchers can improve the experiences of future trial participants and facilitate their choice to remain enrolled in clinica…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Injecting hope
Background This study aimed to assess the feasibility of implementing a community pharmacy–based needle-syringe program (NSP) that provides free needle packs and monetary incentives to recruit people who currently inject drugs for hepatitis C virus (HCV) screening.Method Non-experimental descriptive research study design. Participants were recruited from a community pharmacy NSP in Perth, Western Australia. They received a Fitstick® 5 Plus pack a…
Cupping a solution
Background Hepatitis C is a life-threatening blood-borne virus linked to intravenous drug use. This study aimed to develop the feasibility and acceptability of a new recruitment strategy incentivizing community program for opioid pharmacotherapy clients to undergo hepatitis C virus (HCV) screening.Methods Non-experimental descriptive research study design. Clients received a monetary incentive for returning a cup provided with their opioid substi…
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids
Medicine (9 obras) · HIV, Drug Use, Sexual Risk (7 obras) · Psychiatry (7 obras) · Internal Medicine (5 obras) · Opioid Use Disorder Treatment (5 obras) · Psychology (5 obras) · Substance Abuse Treatment and Outcomes (5 obras) · Hepatitis C virus research (4 obras) · Opioid (4 obras) · Abstinence (3 obras)